Search
for
Sort by
Research 931–960 of 1000+
- Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Autotaxin–lysophosphatidic acid– LPA <sub>3</sub> signaling at the embryo‐epithelial boundary controls decidualization pathways
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Management of Dermatologic Toxicities
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- Development and evaluation of novel rodent model of PCOS mimicking clinical phenotype in human disease
- Phytochemicals for Hair Health Targeting Growth Signaling Molecules in Hair Follicular Stem Cells: A New Strategy for Hair Growth
- Case report: A pregnant woman accidental treated with spironolactone in mid-gestation
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Androgenetic alopecia: An update
- In vitro and In vivo Effects of 17β-N-(4-phenylcarbamoyl) androst-4-en-3- one Derivatives as 5a-reductase Inhibitors on Androgen-dependent Glands
- Progestogens with Antiandrogenic Properties
- Rooster feathering, androgenic alopecia, and hormone-dependent tumor growth: What is in common?
- Identification of Potential Cytochrome p450c 17 Alpha Inhibitors for the Treatment of PCOS via Scaffold Hopping and Fragment-Based De-Novo Drug Design
- Corticotropin releasing factor-1 receptor antagonism associated with favorable outcomes of male reproductive health biochemical parameters
- Triclocarban, Triclosan, Bromochlorophene, Chlorophene, and Climbazole Effects on Nuclear Receptors: An <i>in Silico</i> and <i>in Vitro</i> Study
- Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase
- Nonsteroidal tissue selective androgen receptor modulators: a promising class of clinical candidates
- Nonsteroidal Selective Androgen Receptors Modulators (SARMs): Designer Androgens with Flexible Structures Provide Clinical Promise
- Benzo[<i>c</i>]quinolizin-3-ones: A Novel Class of Potent and Selective Nonsteroidal Inhibitors of Human Steroid 5α-Reductase 1
- Novel Lead Generation through Hypothetical Pharmacophore Three-Dimensional Database Searching: Discovery of Isoflavonoids as Nonsteroidal Inhibitors of Rat 5α-Reductase
- Rational Design and Synthesis of 4-((1<i>R</i>,2<i>R</i>)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a Novel, Nonsteroidal Androgen Receptor Antagonist Devoid of Phototoxicity for Dermatological Indications
- Development of radioiodinated nonsteroidal androgen receptor ligands for spect imaging of prostate cancer
- Natural Product-InspiredBis(trifluoromethyl) PhenylHydroxycinnamate Derivatives as Promising Nonsteroidal Inhibitorsof Human Steroid 5α-Reductase Type-1: Synthesis, <i>InVitro</i>, and <i>In Silico</i> Studies
- Selective non-steroidal inhibitors of 5α-reductase type 1
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Preliminary pharmacokinetics and metabolism of novel non-steroidal antiandrogens in the rat: Relation of their systemic activity to the formation of a common metabolite